Trevogrumab (REGN-1033) is a monoclonal antibody targeting GDF8 (growth differentiation factor 8, also known as muscle growth inhibitor). Trevogrumab is used in studies of sarcopenia, including wasting atrophy, chronic diseases, and changes in food and nutritional intake.
Purity:
>99.0%
CAS Number:
[1429201-24-0]
* VAT and and shipping costs not included. Errors and price changes excepted